Addressing Resistance Through Antimicrobial Stewardship

Target Audience

This educational activity is designed for hospital healthcare professionals, including hospital pharmacists, physicians, microbiologists, infection control personnel, who would benefit from a better understanding of antibiograms to guide clinical decision-making and empiric therapy.

Learning Objectives

After participating in this educational activity, learners should be better able to:

• State the advantages of a combination antibiogram compared to a traditional antibiogram
• Identify core stewardship tactics that promote the appropriate use of antimicrobials
• Describe key steps when developing a business case analysis

Accreditation

Physicians

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Kentucky College of Medicine and Vemco MedEd. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Kentucky College of Medicine designates this Internet Enduring Activity for a maximum of 1.0 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

Pharmacists

Center for Independent Healthcare Education (Center) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Center has assigned 1.0 contact hours (0.1 CEUs) for this activity.

ACPE Universal Activity Number: 473-999-12-006-H01-P

Type of Activity: Knowledge-based

DISCLOSURES

In accordance with policies set forth by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), University of Kentucky UK HealthCare CECentral (UKHCCEC) and Center for Independent Healthcare Education require all faculty members and spouses/significant others with an opportunity to affect the content of a continuing education activity to disclose any relevent financial relationships during the past 12 months with commerical interests. A commercial interest is any entity producing, marketing, reselling or distributing health care goods or services consumed by or used on patients. Relationships with commercial interests and conflicts of interest resulting from those relationships must be revealed to the audience and resolved prior to the activity.

Relevant relationships include roles such as speaker, author, consultant, independent contractor (including research), employee, investor, advisory committee member, board member, review panelist, and investigator. If a potential speaker or author indicates a possible conflict of interest, the conflict will be resolved by choosing another speaker or author for that topical area, or the slides, handouts, and/or monograph will be reviewed and approved by a qualified commerically-disinterested peer.

Planning Committee Members

Christopher Dennison

Dave Feola, PharmD

Paul DeLisle

Marco Cicero, PhD

Janet Hindler, MCLS, MT (ASCP)

Robert P. Rapp, PharmD, FCCP

George G. Zhanel, PharmD, PhD

DISCLOSURE OF FINANCIAL INTEREST SUMMARY

Janet Hindler, MCLS, MT (ASCP) (speaker/planner) has relevant financial relationships with commercial interests as follows:

BD Diagnostics, bioMerieux, Siemens Healthcare Diagnostics - Speaker's Bureau - Honorarium

Forest Laboratories - Advisory Board - Consulting Fee

Ms. Hindler does not intend to discuss the off-label use of a product.

Robert Rapp, PharmD, FCCP (speaker/planner) has relevant financial relationships with commercial interests as follows:

Astellas, Ortho McNeil/Janssen Pharmaceuticals, Pfizer - Speaker - Honorarium

Ortho McNeil/Janssen Pharmaceuticals, Pfizer - Consultant - Honorarium

Dr. Rapp does not intend to discuss the off-label use of a product.

George G. Zhanel, PharmD, PhD (speaker/planner) has relevant financial relationships with commercial interests as follows:

Astellas, Cubist, Ortho McNeil/Janssen Pharmaceuticals - Researcher - Research Funding

Dr. Zhanel does not intend to discuss the off-label use of a product.

No other speakers, authors, planners or content reviewers have any relevant financial relationships to disclose. No other speakers or authors will discuss off-label use of a product. Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.